|
| |
Articles
1-300 out of 500 article(s) next
| Title |
Author |
Type |
Date |
Words |
| Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine. |
|
|
May 17, 2012 |
1204 |
| ImmunoGen, Inc. Announces Presentations at 2012 ASCO Annual Meeting on Product Candidates with the Company's TAP Technology. |
|
|
May 16, 2012 |
805 |
| Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers. |
|
|
May 15, 2012 |
1244 |
| Broad Patent Protection Granted for iBio Immunomodulator. |
|
|
May 8, 2012 |
1114 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. |
|
Conference news |
May 8, 2012 |
297 |
| Temporal trends in Bordetella pertussis populations, Denmark, 1949-2010. |
Petersen, Randi Fons; Dalby, Tine; Dragsted, Ditte Marie; Mooi, Frits; Lambertsen, Lotte |
|
May 1, 2012 |
4740 |
| Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine. |
|
|
May 1, 2012 |
366 |
| ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its Novel IMGN529 Anticancer Compound. |
|
|
Apr 17, 2012 |
802 |
| ImmunoGen, Inc. Announces the IND Is Now Active for Its Folate-Receptor Targeting Anticancer Compound, IMGN853. |
|
|
Apr 17, 2012 |
622 |
| Novel T Cell Antigen Discovery Platform Providing New Momentum on Malaria Vaccine. |
|
|
Apr 11, 2012 |
598 |
| Sublingual immunotherapy an alternative to allergy shots. |
Saporta, Diego |
|
Apr 1, 2012 |
4652 |
| ImmunoGen, Inc. Announces Positive Results in Trastuzumab Emtansine (T-DM1) EMILIA Phase III Trial. |
|
|
Mar 30, 2012 |
864 |
| ImmunoGen, Inc. Announces Conference Call at 8:00 am ET March 30, 2012 to Discuss Today's Favorable Announcements about Trastuzumab Emtansine (T-DM1) and about IMGN901. |
|
|
Mar 30, 2012 |
287 |
| ImmunoGen, Inc. Announces Initiation of Phase II Evaluation of Its IMGN901 Product Candidate. |
|
|
Mar 30, 2012 |
1025 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the Cowen 32nd Annual Health Care Conference. |
|
Conference news |
Mar 2, 2012 |
244 |
| Culturing stool specimens for Campylobacter spp., Pennsylvania, USA. |
M'ikanatha, Nkuchia M.; Dettinger, Lisa A.; Perry, Amanda; Rogers, Paul; Reynolds, Stanley M.; Nacha |
Report |
Mar 1, 2012 |
2795 |
| ImmunoGen, Inc. Adds Two New Directors to the Board. |
|
|
Mar 1, 2012 |
408 |
| ImmunoCellular Therapeutics Licenses Mesothelin Cancer Antigen from Johns Hopkins University. |
|
|
Feb 29, 2012 |
547 |
| Novel therapies for the treatment of metastatic melanoma. |
Chouake, Jason; Friedman, Adam |
Report |
Feb 1, 2012 |
2290 |
| Pevion's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees. |
|
|
Jan 17, 2012 |
831 |
| Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics. |
Peri, Francesco; Calabrese, Valentina; Piazza, Matteo; Cighetti, Roberto |
Report |
Jan 1, 2012 |
3700 |
| Accelerating control of pertussis in England and Wales. |
Campbell, Helen; Amirthalingam, Gayatri; Andrews, Nick; Fry, Norman K.; George, Robert C.; Harrison, |
Clinical report |
Jan 1, 2012 |
7317 |
| The exposure immunogenic protein of viral nervous necrotic on Humpback grouper that influences to proliferation and expression of immune cells (interferon [gamma] and NF-Kb cell). |
Yanuhar, Uun; Gusman, Ery; Arfiati, Diana |
Report |
Jan 1, 2012 |
5329 |
| Generex Announces Airing of Antigen Express Breast Cancer Vaccine Segment on Bloomberg Television. |
|
|
Dec 21, 2011 |
723 |
| Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today. |
|
Clinical report |
Dec 19, 2011 |
1018 |
| Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television. |
|
Clinical report |
Dec 14, 2011 |
1209 |
| NanoBio[R] to Collaborate in Research Effort for Respiratory Syncytial Virus Vaccine With Merck. |
|
|
Dec 8, 2011 |
520 |
| The association between tumour density and prostate cancer recurrence following radical prostatectomy. |
Lavallee, Luke T.; Breau, Rodney H.; Preston, Mark A.; Raju, Gayanna; Morash, Christopher; Doucette, |
Report |
Dec 1, 2011 |
2850 |
| Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay. |
Ahuka-Mundeke, Steve; Ayouba, Ahidjo; Mbala-Kingebeni, Placide; Liegeois, Florian; Esteban, Amandine |
Report |
Dec 1, 2011 |
6908 |
| Preliminary characterization of N-trimethylchitosan as a nanocarrier for malaria vaccine. |
Nnamani, P.O.; Scoles, G.; Krol, S. |
Clinical report |
Dec 1, 2011 |
2379 |
| Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen. |
|
|
Nov 28, 2011 |
758 |
| Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen. |
|
|
Nov 28, 2011 |
762 |
| ImmunoCellular Therapeutics to Present at the 16th Annual Meeting of the Society for Neuro-Oncology. |
|
|
Nov 18, 2011 |
627 |
| Advaxis Licenses Novel Antigen for Severe Breast Cancer and Other Tumor Types. |
|
|
Nov 15, 2011 |
615 |
| Ajuga remota benth.: from ethnopharmacology to phytomedical perspective in the treatment of malaria. |
Cocquyt, K.; Cos, P.; Herdewijn, P.; Maes, L.; Van den Steen, P.E.; Laekeman, G. |
Report |
Nov 15, 2011 |
7465 |
| Common variable immunodeficiency (CVID); a case study. |
Christian, Christian |
Report |
Nov 1, 2011 |
2788 |
| A review of the chemopreventative effects of oral retinoids for internal neoplasms. |
Bhutani, Tina; Koo, John |
Clinical report |
Nov 1, 2011 |
6124 |
| Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? |
Chacon, Gina R.; Sinha, Animesh A. |
Case study |
Nov 1, 2011 |
1771 |
| Research and Markets: Vaccines in Clinical Trials: Cancer - 12 Fascinating Review-Length Articles. |
|
|
Oct 11, 2011 |
397 |
| Research and Markets: Vaccines in Clinical Trials: Infectious Diseases. |
|
|
Oct 11, 2011 |
401 |
| Research and Markets: Lung Cancer Vaccines: 2011 Pipeline, Strategies and Clinical. |
|
Clinical report |
Oct 11, 2011 |
530 |
| Research and Markets: Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical. |
|
|
Oct 7, 2011 |
503 |
| Dietary vitamin E influences the levels of nitric oxide and cytokines in broiler chickens. |
Xu, Jian-xiong; Chen, Xiao-lian; Wang, Jing; Wang, Tian |
Report |
Sep 28, 2011 |
5523 |
| DePEGylation studies: PEG-RBC stability in conditions consistent with massive transfusion. |
Moore, M. Scott; Okelberry, Eric; Cordingley, Krystle; Drake, Alex; Robinett, Zachary |
Report |
Sep 22, 2011 |
3096 |
| Antigen Express' AE37 Cancer Vaccine Featured in Scientific American. |
|
|
Sep 21, 2011 |
1234 |
| Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy. |
|
|
Sep 19, 2011 |
1414 |
| Inovio Pharmaceuticals Completes PENNVAX(TM)-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses. |
|
|
Sep 14, 2011 |
1735 |
| ProImmune Introduces ProPresent Assay for Measurement of Antigen Processing and Presentation. |
|
|
Sep 8, 2011 |
398 |
| A case of lichen planus following tdap vaccination. |
Ghasri, Pedram; Roehmholdt, Brian F.; Young, Lorraine C. |
Clinical report |
Sep 1, 2011 |
1561 |
| IDRI, USAID Strike New Collaboration for Malaria Vaccine Development. |
|
|
Aug 16, 2011 |
781 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the Canaccord Genuity 31st Annual Growth Conference. |
|
Conference news |
Aug 5, 2011 |
250 |
| NanoBio[R] Secures Novel Antigen Source for its Intranasal RSV Vaccine. |
|
|
Aug 3, 2011 |
690 |
| Translating medical evidence to promote informed health care decisions. |
McCormack, Lauren; Treiman, Katherine; Bann, Carla; Williams-Piehota, Pamela; Driscoll, David; Poehl |
|
Aug 1, 2011 |
8359 |
| PharmAthene's rPA Anthrax Vaccine Program Demonstrates 36 Month Product Stability. |
|
|
Jul 12, 2011 |
959 |
| Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology. |
|
|
Jul 11, 2011 |
1324 |
| Epidemiology and control of legionellosis, Singapore. |
Lam, Meng Chon; Ang, Li Wei; Tan, Ai Ling; James, Lyn; Goh, Kee Tai |
Report |
Jul 1, 2011 |
5273 |
| Citrus pectin. |
|
Report |
Jul 1, 2011 |
2791 |
| Scancell Develops New Vaccine for the Treatment of Lung Cancer. |
|
|
Jun 30, 2011 |
797 |
| SCANCELL HOLDINGS PLC - Development of new vaccine for treating lung cancer. |
|
|
Jun 30, 2011 |
842 |
| ImmunoCellular Therapeutics to Present at 2nd World Cancer Vaccines Summit. |
|
|
Jun 22, 2011 |
748 |
| Autoimmune disease: what we do and don't know and how Western medical herbalists can help. |
Harris, Kathy |
Report |
Jun 22, 2011 |
4036 |
| Mintz Levin Represents ImmunoGen, Inc. and Targacept, Inc. in Public Offerings Totaling Approximately $170 Million. |
|
|
Jun 14, 2011 |
188 |
| ImmunoGen, Inc. Earns Milestone with BAY 94-9343 IND Submission. |
|
|
Jun 14, 2011 |
567 |
| OncoSec ElectroImmunotherapy Shows Systemic Effects of Metastatic Melanoma Tumor in More than 50% of Patients. |
|
|
Jun 7, 2011 |
1341 |
| ImmunoGen, Inc. Announces Positive Clinical Data Presented on IMGN901 in the Treatment of Multiple Myeloma. |
|
|
Jun 5, 2011 |
898 |
| ImmunoGen, Inc. Announces Webcast of Presentation at Jefferies 2011 Global Healthcare Conference. |
|
Conference news |
Jun 1, 2011 |
255 |
| A biopsy diagnosis? clinical clues and patterns to help distinguish cutaneous metastases: Part I of II. |
Blecher, Karin; Friedman, Adam |
Report |
Jun 1, 2011 |
3461 |
| ImmunoGen, Inc. Announces Clinical Presentations at the ASCO 2011 Annual Meeting. |
|
|
May 26, 2011 |
714 |
| iBio Announces Successful Production of Critical Hookworm Vaccine Antigen. |
|
|
May 26, 2011 |
984 |
| ImmunoCellular Therapeutics to Present New Data from Phase I Study of ICT-107 in Glioblastoma Multiforme at ASCO 2011. |
|
|
May 24, 2011 |
828 |
| ImmunoGen, Inc. Prices Public Offering of Common Stock. |
|
|
May 20, 2011 |
588 |
| ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock. |
|
|
May 19, 2011 |
538 |
| Article in Current Opinion in Immunology Journal Declares Coming "Decade of DNA Vaccines". |
|
|
May 5, 2011 |
1510 |
| Consortium Awards $23.4 Million for Promising HIV/AIDS Preventive Vaccine Candidate Developed by Institute of Human Virology at the University of Maryland School of Medicine. |
|
|
May 5, 2011 |
1123 |
| ImmunoGen, Inc. Announces Webcast of Presentation at Bank of America Merrill Lynch 2011 Health Care Conference. |
|
Conference news |
May 3, 2011 |
261 |
| Generex Announces Publication on Application of Antigen Express Technology for Early Detection of Type 1 Diabetes. |
|
|
May 3, 2011 |
1045 |
| Adoptive cell transfer targets new cancer antigen. |
McBride, Deborah |
|
May 1, 2011 |
444 |
| Identification of immunogenic relevant antigens in the excretory-secretory (ES) products of Ascaridia galli larvae. |
Garedaghi, Yaghoob |
Report |
May 1, 2011 |
2638 |
| NanoBio[R] Announces Development of Nasal Vaccine for the Prevention of Urinary Tract Infections in Collaboration with the University of Michigan. |
|
|
Apr 20, 2011 |
624 |
| Aduro BioTech Licenses GVAX Pancreas from BioSante Pharmaceuticals to Develop a Therapeutic Vaccine in Conjunction with CRS-207 for Pancreatic Cancer. |
|
|
Apr 18, 2011 |
853 |
| Cross-town rivalry; Two companies vie to create cancer vaccine. |
|
|
Apr 17, 2011 |
1135 |
| T-DM1 Significantly Improved Progression-Free Survival in Randomized Phase II Trial. |
|
|
Apr 7, 2011 |
618 |
| Immunogen Shares Hit New High on Breast Cancer Study Results. |
|
|
Apr 7, 2011 |
423 |
| ImmunoGen, Inc. Announces First Data for its Novel Therapeutic for Ovarian Cancer and Other Carcinomas. |
|
|
Apr 4, 2011 |
865 |
| ImmunoGen, Inc. Announces First Data for Its IMGN529 Product Candidate for Non-Hodgkin's Lymphoma. |
|
|
Apr 4, 2011 |
1275 |
| Management of HIV-hepatitis B co-infection: Southern African HIV Clinicians Society. |
|
|
Apr 1, 2011 |
5542 |
| Routine cryptococcal antigen screening for HIV-infected patients with low CD4+ T-lymphocyte counts--time to implement in South Africa? |
Jarvis, Joseph N.; Harrison, Thomas S.; Govender, Nelesh; Lawn, Stephen D.; Longley, Nicky; Bicanic, |
Report |
Apr 1, 2011 |
2766 |
| Generex Unveils Strategic Development Plan. |
|
|
Mar 30, 2011 |
2881 |
| ImmunoGen, Inc. Announces Presentations at the 102nd Annual Meeting of the American Association for Cancer Research. |
|
|
Mar 30, 2011 |
864 |
| An integrated justice model of wrongful convictions. |
Zalman, Marvin |
|
Mar 22, 2011 |
26701 |
| Tap: novel targets for cancer vaccine development. |
Wilson, Glynn |
|
Mar 1, 2011 |
2089 |
| Effects of the combined stress induced by stocking density and feed restriction on hematological and cytokine parameters as stress indicators in laying hens. |
Kang, Sun-Young; Ko, Young-Hyun; Moon, Yang-Soo; Sohn, Sea-Hwan; Jang, In-Surk |
Report |
Mar 1, 2011 |
4395 |
| Report of increased number of children with parapneumonic empyema as a complication of bacterial pneumonia in West Virginia in 2005. |
Moffett, Kathyrn; Tantoco, Ann-Marie |
Report |
Mar 1, 2011 |
3344 |
| Gene expression alterations in immune system pathways in the thymus after exposure to immunosuppressive chemicals. |
Frawley, Rachel; White, Kimber, Jr.; Brown, Ronnetta; Musgrove, Deborah; Walker, Nigel; Germolec, Do |
Report |
Mar 1, 2011 |
7183 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. |
|
Conference news |
Feb 28, 2011 |
306 |
| Diamyd Medical: Last Patient Completes the EU Phase III Study of Diamyd[R] Antigen Based Therapy for Type 1 Diabetes. |
|
Clinical report |
Feb 14, 2011 |
908 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. |
|
Conference news |
Feb 8, 2011 |
306 |
| Inovio Pharmaceuticals' Dual-Antigen SynCon(TM) DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial. |
|
|
Feb 2, 2011 |
1389 |
| ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2011. |
|
|
Feb 1, 2011 |
268 |
| Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim[TM]) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. |
Madhi, Shabir Ahmed; Cutland, Clare; Jones, Stephanie; Groome, Michelle; Ortiz, Esteban |
Report |
Feb 1, 2011 |
5045 |
| Pfenex Inc. Awarded Sub-contract by Science Applications International Corporation (SAIC) to Help Develop a Scalable Production Process Based on Pfenex Expression Technology(TM) for a Key Malaria Antigen. |
|
|
Jan 26, 2011 |
328 |
| Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells. |
Wang, Hui; Ye, Yan; Pan, Si-Yuan; Zhu, Guo-Yuan; Li, Ying-Wei; Fong, David W.F.; Yu, Zhi-Ling |
Report |
Jan 15, 2011 |
5971 |
| PharmAthene Presents New Anthrax Data at the 5th Annual PHEMCE Stakeholders Workshop and BARDA Industry Day. |
|
|
Jan 13, 2011 |
1518 |
| ImmunoGen, Inc. Announces Webcast of Presentation at J.P. Morgan 29th Annual Healthcare Conference. |
|
Conference news |
Jan 3, 2011 |
276 |
| Particle Sciences Develops Wax Nanoparticles that Enhance Immune Response to Antigens. |
|
|
Dec 22, 2010 |
396 |
| Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways. |
Shyur, Lie-Fen; Lee, Shu-Hua; Chang, Shang-Tzen; Lo, Chiu-Ping; Kuo, Yueh-Hsiung; Wang, Sheng-Yang |
Report |
Dec 15, 2010 |
5620 |
| ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer. |
|
|
Dec 10, 2010 |
998 |
| ImmunoGen, Inc. Announces Presentation of Positive Initial Clinical Data for IMGN901 Used in a Combination Regimen for Multiple Myeloma. |
|
Clinical report |
Dec 4, 2010 |
1094 |
| Markers of inflammation, endothelial activation and autoimmunity in adolescent female gymnasts. |
Alshammari, Eyad; Shafi, Shahida; Nurmi-Lawton, Jaana; Burut, Dayangku Fatiha Pengiran; Lanham-New, |
Report |
Dec 1, 2010 |
7183 |
| Ursolic acid and oleanolic acid, members of pentacyclic triterpenoid acids, suppress TNF-[alpha]-induced E-selectin expression by cultured umbilical vein endothelial cells. |
Takada, K.; T.; Nakane; K.; Masuda; Ishii, H. |
Report |
Dec 1, 2010 |
4381 |
| Today's lab-testing methodologies. |
Flaws, Maribeth Laude |
|
Dec 1, 2010 |
1383 |
| ImmunoGen, Inc. Announces Initiation of Randomized Clinical Trial Evaluating IMGN901 for First-Line Treatment of Small-Cell Lung Cancer. |
|
|
Nov 30, 2010 |
763 |
| Soligenix Announces Issuance of United States Patent for RiVax(TM), its Vaccine Against Ricin Toxin. |
|
|
Nov 22, 2010 |
1652 |
| ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for IMGN388 at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. |
|
|
Nov 19, 2010 |
773 |
| ImmunoGen, Inc. Announces Clinical Data Presentations at the 52nd ASH Annual Meeting and Exposition. |
|
Clinical report |
Nov 17, 2010 |
601 |
| ImmunoGen, Inc. Announces Webcast of Presentation at Lazard Capital Markets 7th Annual Healthcare Conference. |
|
Conference news |
Nov 10, 2010 |
250 |
| ImmunoGen, Inc. Announces Presentations at the 22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics. |
|
|
Nov 2, 2010 |
692 |
| The Alkaline Way: integrative management of autoimmune conditions. |
Jaffe, Russell |
Report |
Nov 1, 2010 |
4643 |
| Dendritic cells and T cells in immunotherapy. |
O'Neill, David W. |
Report |
Nov 1, 2010 |
8607 |
| CTLA4-induced splenomegaly and a review of the literature pertaining to autoimmune complications of therapy. |
Ezra, Navid; Goltche, Natalie B.; Hakimian, Shahrad; Afari, Arash |
Case study |
Nov 1, 2010 |
3346 |
| Immunohistochemical detection of Glut-1 helps to distinguish between reactive mesothelium and malignant mesothelioma. |
Kee, Jing Fung |
Report |
Nov 1, 2010 |
2742 |
| MS Forum/MS over the past 17 years. |
Arnason, B.G.W. |
Clinical report |
Nov 1, 2010 |
4460 |
| Sanofi Pasteur Presents Phase III Data on Intradermal Microinjection of Influenza Vaccine. |
|
|
Oct 25, 2010 |
1526 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. |
|
Conference news |
Oct 19, 2010 |
298 |
| ImmunoGen, Inc. Announces Collaboration for Rights to Use ImmunoGen's TAP Technology. |
|
|
Oct 11, 2010 |
710 |
| ImmunoGen, Inc. Announces Conference Call at 8:30 am ET October 11, 2010 to Discuss New Collaboration and Updated Guidance for Fiscal Year 2011. |
|
|
Oct 11, 2010 |
270 |
| ImmunoGen, Inc. Announces Updated Guidance for 2011 Fiscal Year. |
|
|
Oct 11, 2010 |
490 |
| ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial Comparing Trastuzumab-DM1 vs. Standard First-Line Therapy for First-Line HER2+ Metastatic Breast Cancer. |
|
|
Oct 8, 2010 |
882 |
| BloodCenter of Wisconsin Offers New Service to Reduce Costs of Red Blood Cell Antigen Screening. |
|
|
Oct 8, 2010 |
1008 |
| Celldex Therapeutics Presents Safety and Immunogenicity Data on CDX-1401 at the International Society of Biological Therapy of Cancer Meeting. |
|
|
Oct 4, 2010 |
1050 |
| Detect both HIV antigen and antibodies. |
|
|
Oct 1, 2010 |
123 |
| Does the reflexive measurement of free PSA have a role in a tertiary cancer centre? |
Allard, Christopher; Yip, Paul; Blasutig, Ivan; Hersey, Karen; Fleshner, Neil |
Report |
Oct 1, 2010 |
2613 |
| IgM Dot-ELISA assay using prevalent Leptospira strain for diagnosis of leptospirosis. |
Shekatkar, Smita; Harish, Belgode Narasimha; Parija, Subhash Chandra |
Report |
Oct 1, 2010 |
3059 |
| ImmunoGen, Inc. Announces Start of SAR566658 Clinical Testing. |
|
|
Sep 21, 2010 |
799 |
| Emergent BioSolutions Awarded HHS Contract Valued at up to $186.6 Million to Develop rPA Anthrax Vaccine. |
|
|
Sep 17, 2010 |
771 |
| Inovio Pharmaceuticals Awarded Follow-on Funding from the PATH Malaria Vaccine Initiative for DNA Vaccine Development. |
|
|
Sep 15, 2010 |
1203 |
| Advaxis Publishes Research on New Her2 Vaccine. |
|
|
Sep 10, 2010 |
909 |
| Research and Markets: This Special Expert Review of Vaccines Edition Focuses on the Development Progress of DNA Vaccines for Human Use. |
|
|
Sep 9, 2010 |
505 |
| U.S. Patent and Trademark Office Approves Patent Application That Extends Advaxis Technology to Include HER2/neu for Use in Listeria and Proten Vaccines. |
|
|
Sep 8, 2010 |
941 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Multiple Investor Conferences in September. |
|
Conference news |
Sep 2, 2010 |
339 |
| Analysis of the relationship between MHC-DRB1 gene polymorphism and hydatidosis in Kazakh sheep. |
Li, Ren-Yan; Jia, Bin; Zhang, Wen-Ju; Zhao, Zong-Sheng; Shi, Guo-Qing; Shen, Hong; Peng, Qiang; Lv, |
Report |
Sep 1, 2010 |
3993 |
| Variations of immunoglobulins in colostrum and immune milk as affected by antigen releasing devices. |
Zhao, Shengguo; Zhang, Chungang; Wang, Jiaqi; Liu, Guanglei; Bu, Dengpan; Cheng, Jinbo; Zhou, Lingyu |
Report |
Sep 1, 2010 |
3699 |
| Elevated Atmospheric Carbon Dioxide Concentrations Amplify Alternaria alternata Sporulation and Total Antigen Production. |
Wolf, Julie; O'Neill, Nichole R.; Rogers, Christine A.; Muilenberg, Michael L.; Ziska, Lewis H. |
Report |
Sep 1, 2010 |
6724 |
| The frequency, clinical and laboratory features of RSV in small children with bronchiolitis/Bronsiyolit tanisiyla izlenen kucuk cocuklarda RSV sikligi, klinik ve laboratuvar ozellikleri. |
Kayiran, Sinan Mahir; Paloglu, Erhan; Gurakan, Berkan |
Case study |
Sep 1, 2010 |
2878 |
| Feasible choices in diagnostic methods of malaria. |
Akhtar, Shamim; Maimoon, Sabiha; Wilkinson, Anne; Gowardhan, Vidula; Mahore, Sadhana |
Report |
Sep 1, 2010 |
1947 |
| Serum IGG subclass antibodies to a variety of food antigens in patients with coeliac disease. |
|
Report |
Sep 1, 2010 |
300 |
| Comparative study of commercial food antigen extracts for the diagnosis of food hypersensitivity. |
|
Report |
Sep 1, 2010 |
160 |
| Genentech Receives Refuse to File Letter from FDA for T-DM1. |
|
|
Aug 27, 2010 |
927 |
| European Patent Office Allows Advaxis/U. Penn Modified LLO Patent. |
|
|
Aug 24, 2010 |
766 |
| ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer. |
|
|
Aug 18, 2010 |
750 |
| Emergent BioSolutions and Temasek Life Sciences Ventures Establish Joint Venture to Develop Broad Spectrum Pandemic Flu Vaccine and Therapeutic. |
|
|
Aug 11, 2010 |
1220 |
| Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthrax. |
|
|
Aug 3, 2010 |
386 |
| Statins in skin: research and rediscovery, from psoriasis to sclerosis. |
Egesi, Adaeze; Sun, Grace; Khachemoune, Amor; Rashid, Rashid M. |
Clinical report |
Aug 1, 2010 |
4917 |
| ImmunoGen, Inc. Announces Webcast of Presentation at Upcoming Investor Conferences. |
|
Conference news |
Jul 29, 2010 |
288 |
| PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity. |
|
|
Jul 15, 2010 |
1489 |
| PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health. |
|
|
Jul 8, 2010 |
1218 |
| Neogenix Oncology Files Patent Application For the 16C3 Antigen. |
|
|
Jul 2, 2010 |
533 |
| Merkel cell carcinoma: clinical characteristics, markers, staging and treatment. |
Lien, Mary H.; Baldwin, Brooke T.; Thareja, Sumeet K.; Fenske, Neil Alan |
Report |
Jul 1, 2010 |
4563 |
| Thalidomide and analogues: potential for immunomodulation of inflammatory and neoplastic dermatologic disorders. |
Ladizinski, Barry; Shannon, Edward J.; Sanchez, Miguel R.; Levis, William R. |
Report |
Jul 1, 2010 |
11563 |
| CEL-SCI Collaborator Presents Data Showing LEAPS Vaccine Technology Generates Dendritic Cells That Can Protect Animals against Viral Illness and Other Diseases. |
|
Clinical report |
Jun 28, 2010 |
742 |
| ImmunoGen, Inc. Earns Milestone with Start of SAR650984 Clinical Trial. |
|
|
Jun 24, 2010 |
599 |
| Neogenix Oncology Files Patent Application for the NPC-1C Antigen. |
|
|
Jun 24, 2010 |
390 |
| Inovio Pharmaceuticals' Optimized DNA Vaccine Demonstrates Significant Advantages in Non-Human Primates Compared to Leading Viral Vector Based Vaccine. |
|
|
Jun 22, 2010 |
1293 |
| ImmunoGen, Inc. Announces Vice President Promotions in Product Development. |
|
|
Jun 22, 2010 |
554 |
| FDA Approves First Diagnostic Assay to Detect Both HIV Antigen and Antibodies. |
|
|
Jun 21, 2010 |
709 |
| ImmunoGen, Inc. Announces Encouraging IMGN388 Clinical Data Reported at ASCO. |
|
|
Jun 7, 2010 |
848 |
| ImmunoGen, Inc. Announces Presentation of Clinical Data for Trastuzumab-DM1 at ASCO Annual Meeting. |
|
Clinical report |
Jun 5, 2010 |
1058 |
| ImmunoGen, Inc. Announces Webcast of Presentation at Upcoming Investor Conferences. |
|
Conference news |
Jun 3, 2010 |
215 |
| Study of GSK2132231A antigen-specific cancer immunotherapeutic in patients with inoperable metastatic cutaneous melanoma. |
|
Brief article |
Jun 1, 2010 |
110 |
| Synovial sarcoma of the head and neck: a review of its diagnosis and management and a report of a rare case of orbital involvement. |
Kusuma, Shashidhar; Skarupa, David J.; Ely, Kim A.; Cmelak, Anthony J.; Burkey, Brian B. |
Case study |
Jun 1, 2010 |
2038 |
| High-dose flu vaccine for 2010-2011. |
Schneider, Mary Ellen |
|
Jun 1, 2010 |
353 |
| Plasmodium vivax merozoite surface protein-3[alpha]: a high-resolution marker for genetic diversity studies. |
Prajapati, Surendra Kumar; Joshi, Hema; Valecha, Neena |
Report |
Jun 1, 2010 |
2808 |
| ImmunoGen, Inc. Announces Clinical Data Presentations at Upcoming ASCO Annual Meeting. |
|
|
May 24, 2010 |
607 |
| Celldex Therapeutics Announces Initiation of Randomized Phase 2 Clinical Trial of CDX-1307 in Front Line Bladder Cancer. |
|
|
May 17, 2010 |
1247 |
| High-dose seasonal flu vaccine ready for 2010-2011. |
Schneider, Mary Ellen |
|
May 15, 2010 |
348 |
| SCANCELL HOLDINGS PLC - Replacement - NIH Licensing Agreeme. |
|
|
May 13, 2010 |
621 |
| Research Team at UM Sylvester Comprehensive Cancer Center Develops Novel Strategy to Destroy Tumors Using the Immune System. |
|
|
May 12, 2010 |
721 |
| SCANCELL HOLDINGS PLC - National Institutes of Health Licensing Agreement. |
|
|
May 11, 2010 |
693 |
| ImmunoGen, Inc. Announces Exercise of Over-Allotment Option. |
|
|
May 10, 2010 |
422 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the Bank of America Merrill Lynch Health Care Conference. |
|
Conference news |
May 7, 2010 |
194 |
| ImmunoGen, Inc. Prices Public Offering of Common Stock. |
|
|
May 6, 2010 |
406 |
| ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock. |
|
|
May 5, 2010 |
352 |
| GlycoVaxyn and a Harvard University Affiliated Hospital Receive USD 3.4 Million NIH Grant for Staphylococcus aureus Vaccine Development. |
|
|
May 4, 2010 |
562 |
| Evaluation of Falcivax against Quantitative Buffy Coat (QBC) for the diagnosis of malaria. |
Gurung, Bimala; Bairy, Indira; Jagadishchandra; Manohar, Chetan |
Clinical report |
May 1, 2010 |
2863 |
| Advaxis Chairman/CEO Thomas A. Moore to Present at the World Vaccine Congress 2010. |
|
|
Apr 20, 2010 |
452 |
| ImmunoGen, Inc. Announces Favorable Update Provided by Roche Related to Its Trastuzumab-DM1 Regulatory Plans. |
|
|
Apr 15, 2010 |
494 |
| Genocea Biosciences Enters Into Cooperative Research and Development Agreement with U.S. Military to Develop Malaria Vaccine. |
|
|
Apr 15, 2010 |
667 |
| Serametrix Launches Test for Measuring Serum Antibodies to Leading Cancer Antigen NY-ESO-1. |
|
|
Apr 15, 2010 |
387 |
| Sensitivity and specificity of rapid antigen detection testing for diagnosing pharyngitis in the emergency department. |
Sarikaya, Sezgin; Aktas, Can; Ay, Didem; Cetin, Asli; Celikmen, Ferudun |
Report |
Apr 1, 2010 |
1694 |
| Oral administration of phosphorylated dextran regulates immune response in ovalbumin-immunized mice. |
Nagasawa, Chiho; Nishimura-Uemura, Junko; Tohno, Masanori; Shimosato, Takeshi; Kawai, Yasushi; Ikega |
Report |
Mar 23, 2010 |
4615 |
| Pevion Biotech's PEV7 Vulvovaginal Candidiasis Vaccine Enters Phase I. |
|
|
Mar 22, 2010 |
697 |
| Anti-f in a 24-year old male: a case study. |
Jator, Eleanor K.; Pedde, Ethan |
Case study |
Mar 22, 2010 |
2180 |
| Genocea Biosciences Signs Exclusive License Agreement with Children's Hospital Boston for Novel Streptococcus Pneumoniae Antigens. |
|
|
Mar 18, 2010 |
756 |
| Advaxis Research In ActA Shows Therapeutic Anti-Cancer Response. |
|
|
Mar 18, 2010 |
513 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the 2010 Barclays Capital Global Healthcare Conference. |
|
Conference news |
Mar 18, 2010 |
197 |
| ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU COMP. |
|
|
Mar 8, 2010 |
811 |
| SCANCELL HOLDINGS PLC - Open Offer. |
|
|
Mar 5, 2010 |
5402 |
| USPTO Grants Advaxis New Listeria Based Fusion Protein Patent. |
|
|
Mar 4, 2010 |
588 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences. |
|
Conference news |
Mar 1, 2010 |
280 |
| Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. |
Bousema, Teun; Youssef, Randa M.; Cook, Jackie; Cox, Jonathan; Alegana, Victor A.; Amran, Jamal; Noo |
Survey |
Mar 1, 2010 |
5732 |
| Rhabdomyolysis and pandemic (H1N1) 2009 pneumonia in adult. |
Gutierrez, Ramiro L.; Ellis, Michael W.; Decker, Catherine F. |
Report |
Mar 1, 2010 |
812 |
| Lymphocyte activation in HIV-1 infection: time for quality control. |
Steel, Alan |
Report |
Mar 1, 2010 |
4852 |
| A review of the use of activation markers in Africa. |
John, Laurence; Lutwama, Fred |
Report |
Mar 1, 2010 |
4036 |
| Genocea Biosciences Licenses Extensive Herpes Simplex Virus Patent Estate from the University of Washington. |
|
|
Feb 23, 2010 |
628 |
| ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2010. |
|
|
Feb 3, 2010 |
214 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the 12th Annual BIO CEO & Investor Conference. |
|
Conference news |
Feb 2, 2010 |
196 |
| Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial. |
Al-Bareeq, Reem J.; Ray, A. Andrew; Nott, Linda; Pautler, Stephen E.; Razvi, Hassan |
Clinical report |
Feb 1, 2010 |
3025 |
| Advaxis Issued New Intellectual Property Patent. |
|
|
Jan 22, 2010 |
504 |
| New Study Shows ImmunoCellular Therapeutics' Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells. |
|
|
Jan 20, 2010 |
856 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare Conference. |
|
Conference news |
Jan 6, 2010 |
197 |
| Advaxis Awarded European Patent for New Listeria Vector. |
|
|
Jan 4, 2010 |
577 |
| Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden. |
Nordgren, Johan; Kindberg, Elin; Lindgren, Per-Eric; Matussek, Andreas; Svensson, Lennart |
|
Jan 1, 2010 |
5293 |
| Oral administration of phosphorylated dextran regulates immune response in ovalbumin-immunized mice. |
Nagasawa, Chiho; Nishimura-Uemura, Junko; Tohno, Masanori; Shimosato, Takeshi; Kawai, Yasushi; Ikega |
Report |
Jan 1, 2010 |
4615 |
| Pandemic influenza and emerging diseases in the dental office: update 2009-2010. |
DePaola, Louis G.; Molinari, John |
Report |
Jan 1, 2010 |
6472 |
| Oncology considerations for the patient in acute care. |
Billek-Sawhney, Barbara; Wells, Chris L. |
Report |
Dec 22, 2009 |
7050 |
| ImmunoGen, Inc. Announces Positive Trastuzumab-DM1 Clinical Data Reported at the San Antonio Breast Cancer Symposium. |
|
Clinical report |
Dec 12, 2009 |
840 |
| ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Multiple Myeloma. |
|
Clinical report |
Dec 7, 2009 |
1171 |
| SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at ASH. |
|
|
Dec 7, 2009 |
1069 |
| ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings. |
|
|
Dec 3, 2009 |
258 |
| Novel Intranasal Nanoemulsion Vaccine Adjuvant Also Effective by Subcutaneous and Intramuscular Injection. |
|
|
Dec 2, 2009 |
451 |
| Hormone use after radiotherapy failure: a survey of Canadian uro-oncology specialists. |
Loblaw, D. Andrew; Pickles, Tom; Cheung, Patrick C.; Lukka, Himu; Faria, Sergio; Klotz, Laurence |
Survey |
Dec 1, 2009 |
4007 |
| Anti-allergic effects of scoparone on mast cell-mediated allergy model. |
Choi, Y.H.; Yan, G.H. |
Report |
Dec 1, 2009 |
4205 |
| ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition. |
|
Clinical report |
Nov 24, 2009 |
518 |
| ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Company's TAP Technology. |
|
|
Nov 19, 2009 |
431 |
| ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma. |
|
|
Nov 17, 2009 |
1171 |
| ImmunoGen, Inc. Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders. |
|
|
Nov 11, 2009 |
556 |
| ImmunoGen, Inc. Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. |
|
Conference news |
Nov 10, 2009 |
405 |
| KSU researchers develop antigens. |
|
|
Nov 1, 2009 |
288 |
| Genetic variation of the major histocompatibility complex DRB3.2 locus in the native Bos indicus cattle breeds. |
Behl, Jyotsna Dhingra; Verma, Naresh Kumar; Behl, Rahul; Sodhi, Monika |
Report |
Nov 1, 2009 |
4821 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the Oppenheimer 20th Annual Healthcare Conference. |
|
Conference news |
Oct 27, 2009 |
223 |
| ImmunoCellular Therapeutics Applies for Key Patent Relating to Novel Antigen Targets for Its Monoclonal Antibody Product Candidate. |
|
|
Oct 19, 2009 |
786 |
| NanoBio and the University of Michigan to Receive $9.3M from the NIH for Nanoemulsion-Based Vaccine Development. |
|
|
Oct 13, 2009 |
476 |
| Budlein a from Viguiera robusta inhibits leukocyte-endothelial cell interactions, adhesion molecule expression and inflammatory mediators release. |
Nicolete, Roberto; Arakawa, Nilton S.; Rius, Cristina; Nomizo, Auro; Jose, Peter J.; Costa, Fernando |
Report |
Oct 1, 2009 |
6032 |
| Modulation of in vitro murine B-lymphocyte response by curcumin. |
Decote-Ricardo, D.; Chagas, K.K.F; Rocha, J.D.B.; Redner, P.; Lopes, U.G.; Cambier, J.C.; de Arruda, |
Report |
Oct 1, 2009 |
2832 |
| Poor clinical sensitivity of rapid antigen test for influenza A pandemic (H1N1) 2009 Virus. |
Drexler, Jan Felix; Helmer, Angelika; Kirberg, Heike; Reber, Ulrike; Panning, Marcus; Miller, Marcel |
|
Oct 1, 2009 |
1691 |
| Advaxis Granted New Compositions and Methods Patent. |
|
|
Sep 23, 2009 |
784 |
| Immunophenotypic analysis of bone marrow B lymphocyte precursors (hematogones) by flow cytometry. |
Jmili, N. Braham; Nsaibia, S.; Jacob, M.C.; Omri, H.; Laatiri, M.A.; Yacoub, S.; Braham, Y.; Aouni, |
Clinical report |
Sep 22, 2009 |
3675 |
| Duration of Loxosceles reclusa venom detection by ELISA from swabs. |
McGlasson, David L.; Green, Jonathon A.; Stoecker, William V.; Babcock, James L.; Calcara, David A. |
|
Sep 22, 2009 |
2425 |
| ImmunoGen Announces Amgen has Licensed Rights to Use the Company's TAP Technology for a Solid Tumor Target. |
|
|
Sep 16, 2009 |
406 |
| Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate. |
|
|
Sep 14, 2009 |
960 |
| ImmunoGen, Inc. Announces Webcast of Presentations at Two Investor Conferences. |
|
Conference news |
Sep 2, 2009 |
299 |
| The RAV12 monoclonal antibody recognizes the N-linked glycotope RAAG12: expression in human normal and tumor tissues. |
Coberly, Suzanne K.; Chen, Francine Z.; Armanini, Mark P.; Chen, Yan; Young, Peter F.; Mather, Jenni |
Clinical report |
Sep 1, 2009 |
5430 |
| The U.S. National Institute of Health Awards Advaxis $210,000 for the Development of a Dual Antigen Vaccine. |
|
|
Aug 20, 2009 |
388 |
| Advaxis to Collaborate with City of Hope. |
|
|
Aug 19, 2009 |
620 |
| NanoBio to Present Preclinical Data on its Novel, Nanoemulsion-based Vaccine Adjuvant Platform at the Immunotherapeutics & Vaccine Summit. |
|
|
Aug 17, 2009 |
312 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the 29th Annual Canaccord Adams Global Growth Conference. |
|
Conference news |
Aug 5, 2009 |
224 |
| ImmunoGen Announces Encouraging New Clinical Data with the Company's IMGN901 Compound in the Treatment of Small-Cell Lung Cancer. |
|
|
Aug 1, 2009 |
1689 |
| Reproducibility of serologic assays for influenza virus A (H5N1). |
Stephenson, Iain; Heath, Alan; Major, Diane; Newman, Robert W.; Hoschler, Katja; Junzi, Wang; Katz, |
Report |
Aug 1, 2009 |
6119 |
| Helicobacter pylori vaccine: mucosal adjuvant & delivery systems. |
Sijun, Hu; Yong, Xie |
|
Aug 1, 2009 |
7877 |
| In vitro immunostimulatory properties of Abrus lectins derived peptides in tumor bearing mice. |
Bhutia, Sujit K.; Mallick, Sanjaya K.; Maiti, Tapas K. |
Report |
Aug 1, 2009 |
4873 |
| Limited sampling of radical prostatectomy specimens with excellent preservation of prognostic parameters of prostate cancer. |
Kim, Kyungeun; Pak, Pil June; Ro, Jae Y.; Shin, Dongik; Huh, Soo-Jin; Cho, Yong Mee |
Report |
Aug 1, 2009 |
5377 |
| MS: Is it one disease? |
Barnett, M.H.; Parratt, J.D.E.; Pollard, J.D.; Prineas, J.W. |
Report |
Jul 1, 2009 |
5146 |
| Changes in the activated cytotoxic suppressor T-lymphocytes in elderly patients with mediterranean spotted fever. |
Gospodinova, Margarita D.; Nenova, Marina A.; Mileva, Sevda S. |
Report |
Jul 1, 2009 |
2906 |
| Juvaris BioTherapeutics Announces Strategic Collaboration with Antigen Discovery, Inc. |
|
|
Jun 29, 2009 |
658 |
| ImmunoGen, Inc. Announces Completion of Public Offering of Common Stock. |
|
|
Jun 23, 2009 |
291 |
| New vaccine process proposed; Chemical, not biological method is fast. |
|
|
Jun 23, 2009 |
876 |
| ImmunoGen, Inc. Announces Exercise of Over-allotment Option. |
|
|
Jun 22, 2009 |
442 |
| ImmunoGen, Inc. Prices Public Offering of Common Stock. |
|
|
Jun 18, 2009 |
428 |
| ImmunoGen, Inc. Announces Proposed Public Offering of Common Stock. |
|
|
Jun 17, 2009 |
386 |
| Research and Markets: Vaccine Antigen Delivery Technologies - Molecular Systems to Open New Markets. |
|
|
Jun 12, 2009 |
407 |
| ImmunoGen, Inc. Elects to Discontinue Further Internal Development of Its IMGN242 Compound. |
|
|
Jun 11, 2009 |
586 |
| Advaxis Develops Innovative Approach in Cancer Mechanism Targeting. |
|
|
Jun 1, 2009 |
395 |
| Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice. |
Li,; Gong, Xia; Zhang, Li; Zhang, Zhuo; Luo, Fuling; Zhou, Qixin; Chen, Jin; Wan, Jingyuan |
Report |
Jun 1, 2009 |
4872 |
| Galactomannan assay and plasma protein electrophoresis findings in psittacine birds with Aspergillosis. |
Cray, Carolyn; Reavill, Drury; Romagnano, April; Van Sant, Fern; Champagne, Daphne; Stevenson, Rhoda |
Report |
Jun 1, 2009 |
7486 |
| J Zoo Wildl Med.: Application of galactomannan analysis and protein electrophoresis in the diagnosis of aspergillosis in avian species. |
Cray, C.; Watson, T.; Rodriguez, M.; Arheart, K.L. |
Brief article |
Jun 1, 2009 |
194 |
| ImmunoGen, Inc. Announces Encouraging Trastuzumab-DM1 Phase II Clinical Findings Presented at ASCO. |
|
|
May 30, 2009 |
737 |
| CSL Biotherapies Contracts with U.S. Department of Health and Human Services (HHS) to Provide Novel A (H1N1) Influenza Vaccine Antigen. |
|
|
May 29, 2009 |
413 |
| Advaxis Receives US Patent and Trademark Office Approval on Act-A Protein Patent-Pending Rights. |
|
|
May 26, 2009 |
456 |
| ImmunoGen, Inc. Announces Trastuzumab-DM1 Presentations at the 2009 American Society for Clinical Oncology Annual Meeting. |
|
|
May 14, 2009 |
621 |
| Advaxis Scientific Founder Published in Prestigious Peer-Reviewed Journal of Immunology. |
|
|
May 11, 2009 |
682 |
| Research and Markets: Therapeutic Cancer Vaccines - Evolving Strategies and Pipeline Prospects Revealed. |
|
|
May 7, 2009 |
345 |
| Advaxis Applies for Approximately $5.0 Million in Grants in Response to U.S. Department of Defense Solicitation. |
|
|
May 4, 2009 |
668 |
| Epithelioid sarcoma. |
Armah, Henry B.; Parwani, Anil V. |
Clinical report |
May 1, 2009 |
3846 |
| Dynavax Presents Data From Novel Universal Flu Vaccine Candidate. |
|
|
Apr 30, 2009 |
790 |
| Experts Available to Discuss: US Responding as If Swine Flu Will Be Pandemic. |
|
|
Apr 28, 2009 |
917 |
| Advaxis Applies for Approximately $1.0 Million Worth of Grants from the National Institute of Health. |
|
|
Apr 27, 2009 |
489 |
| NanoBio Initiates FDA Approved Clinical Trial for Adjuvanted Intranasal Influenza Vaccine. |
|
|
Apr 20, 2009 |
578 |
| ImmunoGen, Inc. Announces Presentations at the American Association for Cancer Research Annual Meeting. |
|
|
Apr 10, 2009 |
649 |
| Production of a his-tag recombinant far protein and analysis of the lifecycle stages of Hp-FAR-1. |
Bath, Jennifer L.; Kennedy, Malcolm W.; Drees, Jeremy; Maetzold, Erin; Scheidt, Michael; Knox, Megan |
Abstract |
Apr 1, 2009 |
537 |
| Primary pulmonary follicular dendritic cell neoplasm: a case report and review of the literature. |
Denning, Krista L.; Olson, Peter R.; Maley, Richard H., Jr.; Flati, Veronica R.; Myers, Jeffrey L.; |
Case study |
Apr 1, 2009 |
3010 |
| VGX Pharmaceuticals Announces Agreement With the PATH Malaria Vaccine Initiative. |
|
|
Mar 23, 2009 |
385 |
| Section V: Biomedical Sciences. |
|
|
Mar 22, 2009 |
1747 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the Barclays Capital Global Healthcare Conference. |
|
Conference news |
Mar 3, 2009 |
208 |
| ImmunoGen, Inc. Earns Milestone Payment with Genentech's Start of Trastuzumab-DM1 (T-DM1) Phase III Clinical Testing; Other T-DM1 Progress Reported. |
|
|
Mar 2, 2009 |
498 |
| A closer look at asthma, part II. |
Wojciechowski, Bill |
|
Mar 1, 2009 |
1227 |
| Silibinin attenuates antigen-specific IgE production through the modulation of Th1/Th2 balance in ovalbumin-sensitized BALB/c mice. |
Kuo, Fu-Hua; Jan, Tong-Rong |
Report |
Mar 1, 2009 |
2396 |
| VGX Pharmaceuticals Avian Influenza DNA Vaccine Delivered with Electroporation Provides 100% Protection of Non-Human Primates. |
|
|
Feb 23, 2009 |
753 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the BIO CEO & Investor Conference 2009. |
|
Conference news |
Feb 2, 2009 |
191 |
| ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009. |
|
|
Jan 28, 2009 |
210 |
| IAVI and Algonomics to Collaborate on HIV Protein Design Project. |
|
|
Jan 26, 2009 |
964 |
| Advaxis Files 8-K on European Patent Appeal. |
|
|
Jan 16, 2009 |
569 |
| Advaxis Prevails in European Patent Court. |
|
|
Jan 14, 2009 |
755 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the 27th Annual J.P. Morgan Healthcare Conference. |
|
Conference news |
Jan 8, 2009 |
174 |
| Murine monoclonal anti-H as typing reagent. |
Iyer, Y.S.; Vasantha, K.; Pujari, V.; Jadhav, S.; Ghosh, K. |
Report |
Jan 1, 2009 |
1481 |
| Influenza vaccination for health care workers: towards a workable and effective standard. |
Rodal, Rebecca; Ries, Nola M.; Wilson, Kumanan |
|
Jan 1, 2009 |
16754 |
| ImmunoGen, Inc. Announces Favorable IMGN901 Clinical Findings Reported at ASH Annual Meeting. |
|
Clinical report |
Dec 9, 2008 |
771 |
| ImmunoGen, Inc. Announces Genentech's Fifth TAP Technology License. |
|
|
Dec 8, 2008 |
352 |
| Allergic bronchopulmonary aspergillosis in patients with moderate and severe asthma/ Orta ve agir astimli olgularda Alerjik bronkopulmoner aspergilloz. |
Aydogan, Oznur; Erdinc, Munevver; Aytemur, Zeynep Ayfer; Sin, Aytul; Savas, Recep |
Report |
Dec 1, 2008 |
3398 |
| ImmunoGen, Inc. Announces Webcast of Presentation at the Lazard Capital Markets 5th Annual Healthcare Conference. |
|
Conference news |
Nov 11, 2008 |
191 |
| Detection of Chlamydophila pneumoniae (Chlamydia pneumoniae) in endarteroctomy specimens of coronary heart diseases patients. |
Satpathy, Gita; Bhan, Anil; Sharma, Anjana; Kar, U.K. |
|
Nov 1, 2008 |
2723 |
|
